Hopes for a successful coronavirus vaccine have been raised after University of Oxford researches signalled a potential breakthrough while testing their prototype. The news comes on the heels of similarly strong results from a study in the United States.
Human trials carried out by Oxford researchers reportedly showed their vaccine prototype had successfully generated an immune response against the virus.
Britain’s Daily Telegraph newspaper said blood samples taken from some 1,000 volunteers in phase 1 trials showed the vaccine had stimulated encouraging levels of antibodies and T-cells. No serious side effects were reported.
“We now know the Oxford vaccine covers both bases – it produces both a T-cell and an antibody response,” an unnamed source told the Telegraph. A separate source said this meant the vaccine could offer “double protection” against the virus. RFI.
.jpeg)